Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
t-cell crawled date : 2021 - 12 - 09 save search
Denovo Biopharma and QIAGEN partner to develop companion diagnostic test for the treatment of Diffuse Large B-Cell Lymphoma (DLBCL)
Published: 2021-12-09 (Crawled : 19:00) - biospace.com/
QGEN | $41.89 1.63% 0.0% 900K
|
Health Technology
|
| O: 0.82%
H: 0.29%
C: -1.35%
QGEN | $41.89 1.63% 0.0% 900K
|
Health Technology
|
| O: 0.82%
H: 0.29%
C: -1.35%
diagnostic treatment biopharma test t-cell
Atara Biotherapeutics Announces Preliminary Results for ATA2271, a Next-Generation Autologous Mesothelin-targeted CAR T-cell Therapy for Solid Tumors, at ESMO Immuno-Oncology Congress 2021
Published: 2021-12-09 (Crawled : 14:00) - biospace.com/
ATRA | $0.7199 3.23% 3.13% 830K
|
Health Technology
|
| O: -2.59%
H: 1.04%
C: -5.89%
ata2271 solid tumors therapeutics therapy results iot t-cell
Mustang Bio to Host Key Opinion Leader Webinar on MB-106, a Potential Treatment for B-Cell Non Hodgkin Lymphomas and Chronic Lymphocytic Leukemia
Published: 2021-12-09 (Crawled : 14:00) - globenewswire.com
MBIO | $0.3355 -1.32% -1.34% 120K
|
Health Technology
|
| O: 2.88%
H: 1.87%
C: -3.27%
FBIO | $1.79 2.29% 2.23% 190K
|
Health Technology
|
| O: 4.85%
H: 0.0%
C: 0.0%
mb-106 treatment leukemia potential lymphomas t-cell
Achilles Therapeutics Presents Positive Data at ESMO I-O Congress 2021 on High-Dose Manufacturing Process for Precision T Cell Therapies Targeting Clonal Neoantigens
Published: 2021-12-09 (Crawled : 12:30) - globenewswire.com
ACHL | $0.781 -1.14% -1.15% 110K
|
Manufacturing
|
| O: 5.43%
H: 6.09%
C: -5.15%
therapeutics positive t-cell
Greenwich LifeSciences Announces Presentation of 5 Year Data for GP2 Phase IIb Clinical Trial, Revealing Potential For New T Cell Platform Technology
Published: 2021-12-09 (Crawled : 12:30) - biospace.com/
GLSI | $13.12 3.39% 3.28% 36K
|
Health Technology
|
| O: 4.11%
H: 0.9%
C: -12.42%
technology trial presentation potential platform t-cell
QIAGEN and Denovo Biopharma Partner to Develop Companion Diagnostic Test for the Treatment of Diffuse Large B-Cell Lymphoma (DLBCL)
Published: 2021-12-09 (Crawled : 08:00) - biospace.com/
QGEN | $41.89 1.63% 0.0% 900K
|
Health Technology
|
| O: 0.82%
H: 0.29%
C: -1.35%
QGEN | $41.89 1.63% 0.0% 900K
|
Health Technology
|
| O: 0.82%
H: 0.29%
C: -1.35%
diagnostic treatment biopharma test t-cell
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.